Dopamine

"Dopamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.

Descriptor ID	D004298
MeSH Number(s)	D02.092.211.215.311.342 D02.092.311.342
Concept/Terms	Dopamine Dopamine 4-(2-Aminoethyl)-1,2-benzenediol Hydroxytyramine 3,4-Dihydroxyphenethylamine 3,4 Dihydroxyphenethylamine Dopamine Hydrochloride Dopamine Hydrochloride Hydrochloride, Dopamine Intropin Intropin

Below are MeSH descriptors whose meaning is more general than "Dopamine".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amines [D02.092]
Biogenic Amines [D02.092.211]
Biogenic Monoamines [D02.092.211.215]
Catecholamines [D02.092.211.215.311]
Dopamine [D02.092.211.215.311.342]
Catecholamines [D02.092.311]
Dopamine [D02.092.311.342]

Below are MeSH descriptors whose meaning is related to "Dopamine".

Below are MeSH descriptors whose meaning is more specific than "Dopamine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dopamine" by people in this website by year, and whether "Dopamine" was a major or minor topic of these publications.

Bar chart showing 63 publications over 21 distinct years, with a maximum of 10 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
1998	1	1	2
2000	0	1	1
2001	1	2	3
2002	1	1	2
2003	2	1	3
2004	1	1	2
2005	1	3	4
2006	1	4	5
2007	3	1	4
2008	3	0	3
2009	7	3	10
2010	1	1	2
2011	6	0	6
2012	2	2	4
2013	3	0	3
2014	2	1	3
2016	0	1	1
2020	1	0	1
2022	0	2	2

Below are the most recent publications written about "Dopamine" by people in Profiles.

Froehlich M, Koizumi N, James RM, Christian AGW, Choubey A, Patel S, Ortiz J, Siskind EJ. The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure. Pancreas. 2022 08 01; 51(7):747-751.

View in: PubMed
Smeyne RJ, Eells JB, Chatterjee D, Byrne M, Akula SM, Sriramula S, O'Rourke DP, Schmidt P. COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism. Mov Disord. 2022 07; 37(7):1394-1404.

View in: PubMed
Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration. Am J Health Syst Pharm. 2020 Apr 01; 77(8):649-657.

View in: PubMed
Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, Wei X, Bazzan AJ, Zhong L, Bowen B, Intenzo CM, Iacovitti L, Newberg AB. N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data. PLoS One. 2016; 11(6):e0157602.

View in: PubMed
Iacovitti L, Wei X, Cai J, Kostuk EW, Lin R, Gorodinsky A, Roman P, Kusek G, Das SS, Dufour A, Martinez TN, Dave KD. The hTH-GFP reporter rat model for the study of Parkinson's disease. PLoS One. 2014; 9(12):e113151.

View in: PubMed
McKimm E, Corkill B, Goldowitz D, Albritton LM, Homayouni R, Blaha CD, Mittleman G. Glutamate dysfunction associated with developmental cerebellar damage: relevance to autism spectrum disorders. Cerebellum. 2014 Jun; 13(3):346-53.

View in: PubMed
Simpson EH, Morud J, Winiger V, Biezonski D, Zhu JP, Bach ME, Malleret G, Polan HJ, Ng-Evans S, Phillips PE, Kellendonk C, Kandel ER. Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum. Learn Mem. 2014 Mar 17; 21(4):205-14.

View in: PubMed
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, D?vila-Rom?n VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.

View in: PubMed
Rogers TD, Dickson PE, McKimm E, Heck DH, Goldowitz D, Blaha CD, Mittleman G. Reorganization of circuits underlying cerebellar modulation of prefrontal cortical dopamine in mouse models of autism spectrum disorder. Cerebellum. 2013 Aug; 12(4):547-56.

View in: PubMed
Smeyne M, Smeyne RJ. Glutathione metabolism and Parkinson's disease. Free Radic Biol Med. 2013 Sep; 62:13-25.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement